0.914
Precedente Chiudi:
$0.9157
Aprire:
$0.93
Volume 24 ore:
22,934
Relative Volume:
0.10
Capitalizzazione di mercato:
$56.13M
Reddito:
-
Utile/perdita netta:
$-112.67M
Rapporto P/E:
-0.4687
EPS:
-1.95
Flusso di cassa netto:
$-79.26M
1 W Prestazione:
-4.79%
1M Prestazione:
-10.39%
6M Prestazione:
-3.79%
1 anno Prestazione:
-19.82%
Kronos Bio Inc Stock (KRON) Company Profile
Nome
Kronos Bio Inc
Settore
Industria
Telefono
(650) 781-5200
Indirizzo
1300 S. EL CAMINO REAL, SAN MATEO
Confronta KRON con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
KRON
Kronos Bio Inc
|
0.922 | 56.13M | 0 | -112.67M | -79.26M | -1.95 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
503.65 | 130.68B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
666.97 | 74.97B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
602.98 | 36.08B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
240.89 | 31.19B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
257.16 | 27.56B | 3.32B | -860.46M | -1.04B | -8.32 |
Kronos Bio Inc Stock (KRON) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-14 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-11-14 | Downgrade | TD Cowen | Buy → Hold |
2022-09-14 | Iniziato | Berenberg | Buy |
2021-10-20 | Ripresa | Cowen | Outperform |
2021-06-24 | Iniziato | H.C. Wainwright | Buy |
2020-11-03 | Iniziato | Cowen | Outperform |
2020-11-03 | Iniziato | Goldman | Buy |
2020-11-03 | Iniziato | Jefferies | Buy |
2020-11-03 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Kronos Bio Inc Borsa (KRON) Ultime notizie
Kronos Bio (KRON) to Release Quarterly Earnings on Thursday - Defense World
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
Kronos Bio Insider Ups Holding By 36% During Year - Yahoo Finance
Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat
Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN
Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat
Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia
Kronos Bio ends partnership with Genentech - Investing.com India
Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks
Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat
Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE
Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates - MSN
KRON (Kronos Bio) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
A Look At The Behavior Of Kronos Bio Inc (KRON) Stock - Stocks Register
Kronos Bio announces interim CEO; over 80% of staff reduction - MSN
Kronos Bio announces interim CEO and workforce cuts of 83% - Yahoo Finance
Strategic shift at Kronos creates CEO vacancy - The Pharma Letter
Kronos Bio to lay off 83% of staff as CEO steps down - The Business Journals
Kronos Bio announces layoffs and executive changes By Investing.com - Investing.com Nigeria
Kronos Bio, Inc. Announces Management Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio, Inc. Announces CEO Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio Shakes Up LeadershipCuts 83% Of Workforce Amid Strategic Overhaul - AOL
Kronos Bio Inc Azioni (KRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kronos Bio Inc Azioni (KRON) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 28 '24 |
Buy |
1.25 |
204,670 |
254,957 |
10,802,138 |
BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 10 '24 |
Buy |
0.88 |
1,378,901 |
1,208,469 |
5,749,395 |
BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 12 '24 |
Buy |
1.24 |
881,913 |
1,096,041 |
7,375,616 |
BISCHOFBERGER NORBERT W | PRESIDENT & CEO |
Jun 11 '24 |
Buy |
1.09 |
744,308 |
814,571 |
6,493,703 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):